Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency. - Wikidata - wikimedia - TriplyDB

Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

http://www.wikidata.org/entity/Q36660112

about

Management of epilepsy during pregnancy: an update Medical management of epileptic seizures: challenges and solutions Pharmacotherapy for mood disorders in pregnancy: a review of pharmacokinetic changes and clinical recommendations for therapeutic drug monitoring Pregnancy-Associated Changes in Pharmacokinetics: A Systematic Review Hormonal aspects of epilepsy.MODEL-BASED LAMOTRIGINE CLEARANCE CHANGES DURING PREGNANCY: CLINICAL IMPLICATION.Carbamazepine clearance and seizure stability during pregnancy.Pharmacogenetics and individualizing drug treatment during pregnancy.Preschool outcomes following prenatal serotonin reuptake inhibitor exposure: differences in language and behavior, but not cognitive function.Antiepileptic drugs in women with epilepsy during pregnancy Therapeutic Drug Monitoring of the Newer Anti-Epilepsy Medications Perinatal exposure to maternal lamotrigine: clinical considerations for the mother and child Advances in epilepsy: new perspectives on new-onset epilepsy, comorbidities, and pharmacotherapy.Practice parameter update: management issues for women with epilepsy--focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding: report of the Quality Standards Subcommittee and Therapeutics and Technology Antiepileptic drugs during pregnancy: what is known and which AEDs seem to be safest?Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release Brand spanking? The presumptive risks of generic antiepileptic drugs.Too Complicated or So Simple: AED Type and AED Dose Matter for Pregnancy.Prenatal antiepileptic exposure associates with neonatal DNA methylation differences.Hormones, seizures, and lamotrigine: Oh, my!AED Treatment Through Different Ages: As Our Brains Change, Should Our Drug Choices Also?Does increased levetiracetam clearance during pregnancy require planned intervention?Postpartum depression in women with epilepsy: influence of antiepileptic drugs in a prospective study.Trends in maternal deaths from epilepsy in the United Kingdom: a 30-year retrospective review.Antiepileptic drug clearance and seizure frequency during pregnancy in women with epilepsy.Do lamotrigine and levetiracetam solve the problem of using sodium valproate in women with epilepsy?Up-regulation of UDP-glucuronosyltransferase (UGT) 1A4 by 17beta-estradiol: a potential mechanism of increased lamotrigine elimination in pregnancy The management of epilepsy in pregnancy at the Whittington Hospital: a retrospective audit 2004-2006 and 2007-2010.Women with epilepsy planning pregnancy: we can improve outcomes by improving care Lamotrigine use in pregnancy.Antiepileptic drug treatment in pregnancy: changes in drug disposition and their clinical implications.Basic obstetric pharmacology.Transcriptional regulation of human UDP-glucuronosyltransferase genes.Safety of anticonvulsant agents in pregnancy.Sodium Channel Blockers in the Treatment of Epilepsy.Therapeutic Index Estimation of Antiepileptic Drugs: A Systematic Literature Review Approach.Pharmacotherapy in pediatric epilepsy: from trial and error to rational drug and dose selection - a long way to go.A pharmacological overview of lamotrigine for the treatment of epilepsy.Use of Antiepileptic Drugs During Pregnancy: Evolving Concepts.Brand Spanking II: Attack of the Clones (or, The Phantom Menace).

P2860

Q26752470-85658796-6A3B-4D17-B773-E8DD39200FFD Q26766413-C8D99D85-EAA8-4FAB-A45E-57D07434EBFD Q27027293-BCF47051-3E15-4501-B491-8DF160C0DFC2 Q28109657-D99DA69C-60C1-41BE-AD56-857E544BCF38 Q33638313-A53F8707-99A6-4066-82FA-B4401E693980 Q33683865-A442FF39-DDBE-4CD8-A302-E967D8579490 Q33696210-061B0796-3111-4048-94FF-D29DB0DBE909 Q33781272-66DBF6D6-D9D0-47B9-8979-E98A54EEF812 Q33907544-5B428C1D-1FD6-4AA1-9188-3D7C92EE2837 Q33949402-0A0B3222-AF7F-406A-9DFC-A763A632253C Q33996679-48893AF0-C48B-4D04-8BC9-B71BE84282E9 Q34305635-11011757-2D85-4594-B55A-39DFA51DECB5 Q34343400-9695512D-7D9E-463C-BEAA-3CD08F6A339C Q34606995-552077DC-5F03-4B19-A683-F57ECFB583E6 Q34905287-C3B4E60A-3D1B-48E7-BDEC-EF4B82F3F557 Q34942400-8104C978-FB32-40BD-A5B3-D729E153796E Q35052165-5FD6173A-1F44-4408-AECC-427E96B08A29 Q35862647-4C7760DF-0A8E-4558-8653-AD91ECCDAFEC Q36012665-663C82D7-3E57-4763-96DD-3730BC5D6A4F Q36453496-3B654FA5-F3C3-4430-8CDC-7F18E636B927 Q36656367-517AFA1C-5BDB-4AFA-A7E2-20008C3EFC1D Q36658100-CBA471FF-BC43-4505-834B-1DCED0793C63 Q36660100-77384CD8-133B-41ED-A5A9-80C8174AEA03 Q37070406-F0DC8A4A-4CC0-44B3-8E37-B149665816CF Q37179423-6DF09DF0-B2C5-47B8-B840-1770DFA13EA7 Q37186130-FDA7FEF5-C2B4-4ABA-B504-BE4F005EB837 Q37311627-6CB9CF80-E7CF-4205-879E-461A7452C2D0 Q37315283-0E773ACF-DAD5-41F0-96F5-FAE01E8CA2FE Q37372213-AEE92842-CD01-4E77-944F-19D7DA40AAB7 Q38010785-174DEA66-4D4E-4315-8F2C-3C77C2782879 Q38077586-4E12305B-2A7C-4A3C-8D01-4B3ADB3BA82E Q38256590-0D6B9340-917E-4E00-8517-93F6CD19DB66 Q38261875-7B290AEE-A87C-48EB-ACFD-9401D6BA07F3 Q38577939-CA8443D9-29A5-4F76-9D54-E73EE6127258 Q38775516-475BFD2B-6C76-45DE-A22D-616E08FC6F6D Q38840677-98BFD95D-95F1-4539-B100-379F52DD8231 Q38902279-6982AA5F-E616-499F-8C47-8AC27D606BC5 Q39002973-908CF540-5921-4D2E-AAF3-1C4DB1661A40 Q39510801-5B3BD24E-789C-4CD2-9CBB-FD73E3A75A6C Q41596638-B12A755B-75B0-42B3-8CD9-19C7DB5CE924

P2860

Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

http://www.wikidata.org/entity/Q36660112

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

@ast

Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

@en

type

label

Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

@ast

Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

@en

prefLabel

Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

@ast

Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

@en

P1433

Q36660112-E58556CA-E9B4-4044-A7F7-7B493663E8A4

P1476

Q36660112-E8D6B736-686C-4B7F-A369-F61A2078763B

P2093

Q36660112-1463A434-C246-425A-8DFB-B01BB5A3CF12

Q36660112-1FFDE777-5EC1-4494-9FF0-597FA2129E8B

Q36660112-5A22D8FF-D45C-4236-8662-F8084AF9C4CA

Q36660112-AD72C73D-4C85-4A27-93E0-7417FA10EEBB

Q36660112-D3DC3F62-2A53-4253-ADDC-8B20D5DCC6EB

Q36660112-D3F4BA77-E115-4B30-99AF-80156169FCEA

Q36660112-E874555B-99A5-40E8-A919-7623F8543FCE

Q36660112-F2E98621-DAD1-4EEA-B1A8-052E0C000F4A

P2860

Q36660112-02171A02-03AF-44DF-A88A-0CB7B7F1E29D

Q36660112-038C9656-68BF-4E37-AA6E-839C662F19BB

Q36660112-0F7353B8-A4CE-43FA-8E88-2E807DCC10F8

Q36660112-11077840-FC84-437A-BCEB-4EFD2DEE5026

Q36660112-16A06B3A-D028-4133-BEA3-B98305CE7C06

Q36660112-2048DA89-12D6-4C3B-A44B-A946A71A0F65

Q36660112-26D422DB-6D64-496C-87D7-C72CA6D7FFFE

Q36660112-29D859AD-32D7-44ED-8A6A-F43761D2C888

Q36660112-2FDF1C4E-EA1C-4E2F-A3E3-A1E9590866CE

Q36660112-3CCEEFCA-6279-44EA-BAF6-477C80500D5A

P304

Q36660112-85E6B8F3-7690-4077-B87C-FEBB7208B0ED

P31

Q36660112-A029403A-FAC4-4005-B354-C873D2D7AE2A

P356

Q36660112-6FE3955A-DBA0-4937-A625-364BEA619F67

P407

Q36660112-A180F45C-9BC1-49BD-BC3D-26950D292C28

P433

Q36660112-BABDCD7F-90DB-4127-B66D-FBB9DF898921

P478

Q36660112-6C94361C-247F-4EC5-AEF4-A1AA88377949

P577

Q36660112-DF5B36F6-D693-461C-AEF3-F23968741420

P5875

Q36660112-C67F9CBA-9687-4F9F-B64B-1055CB1A22F2

P698

Q36660112-3DA98CA6-B91C-4BD8-9E7C-55A929203C5A

P932

Q36660112-29C93AC4-3105-4B07-905C-A0F19B05B224

P356

01.WNL.0000289511.20864.2A

P1433

P1476

Lamotrigine in pregnancy: clearance, therapeutic drug monitoring, and seizure frequency.

@en

P2093

A Koganti

http://www.w3.org/2001/XMLSchema#string

D J Newport

http://www.w3.org/2001/XMLSchema#string

D K Holley

http://www.w3.org/2001/XMLSchema#string

J C Ritchie

http://www.w3.org/2001/XMLSchema#string

L Peng

http://www.w3.org/2001/XMLSchema#string

M Newman

http://www.w3.org/2001/XMLSchema#string

P B Pennell

http://www.w3.org/2001/XMLSchema#string

Z N Stowe

http://www.w3.org/2001/XMLSchema#string

P2860

Glucuronidation of amines and other xenobiotics catalyzed by expressed human UDP-glucuronosyltransferase 1A3

Foetal malformations and seizure control: 52 months data of the Australian Pregnancy Registry.

Change of seizure frequency in pregnant epileptic women

Using current evidence in selecting antiepileptic drugs for use during pregnancy.

Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations.

In utero antiepileptic drug exposure: fetal death and malformations

Antiepileptic drug pharmacokinetics during pregnancy and lactation.

Management of bipolar disorder during pregnancy and the postpartum period.

Risks and management of pregnancy in women with epilepsy.

Pregnancy in women who have epilepsy.

P304

2130-2136

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/01.WNL.0000289511.20864.2A

http://www.w3.org/2001/XMLSchema#string

P407

P433

22 Pt 2

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2007-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5801935

http://www.w3.org/2001/XMLSchema#string

P698

18046009

http://www.w3.org/2001/XMLSchema#string

P932

3589527

http://www.w3.org/2001/XMLSchema#string